A Selective Nuclear Factor-κB Inhibitor, JSH-23, Exhibits Antidepressant-like Effects and Reduces Brain Inflammation in Rats

Altogether, these data suggest that NF-κB may be a potential therapeutic target for pharmacological interventions for depression.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2024-09-26
DOI
https://doi.org/10.3390/ph17101271
Citations
2
Primary Topic
Tryptophan and brain disorders
Type
article
Field-Weighted Citation Impact
0.31
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Selective Nuclear Factor-κB Inhibitor, JSH-23, Exhibits Antidepressant-like Effects and Reduces Brain Inflammation in Rats

Abed N. Azab, J. Kaplanski, Ahmad Nassar
2 citations
Pharmaceuticals
Tryptophan and brain disorders
0.31
article

A Selective Nuclear Factor-κB Inhibitor, JSH-23, Exhibits Antidepressant-like Effects and Reduces Brain Inflammation in Rats

Abed N. Azab, J. Kaplanski, Ahmad Nassar
article en
2 citations

Abstract

Altogether, these data suggest that NF-κB may be a potential therapeutic target for pharmacological interventions for depression.

PharmaceuticalsVol. 17(10)
Ben-Gurion University of the Negev (IL)
Openalex Percentile: Top 49%
Tryptophan and brain disorders
0.31
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Selective Nuclear Factor-κB Inhibitor, JSH-23, Exhibits Antidepressant-like Effects and Reduces Brain Inflammation in Rats — Abed N. Azab, J. Kaplanski, et al. · Pharmaceuticals (2024) | TGRS Research Map | TGRS